Strolling Poster Sessions – 14 November 2026

The Strolling Poster Sessions will take place on 14 November 2026, across two consecutive time slots and two designated poster areas.

Please refer to the schedule below to identify your presentation time and assigned poster area.


12:30–13:15
Poster Area I
Poster Area II 
Session 1
Session 2
Session 3
Session 4
Session 5
Session 6
Session 7


13:15–14:00
Poster Area I 
Poster Area II
Session 9
Session 8
Session 11
Session 10
Session 13
Session 12
 

Important information for Poster Presenters

 

Poster Session 1 – Diagnosis

Chairs: Takanori Asakura (Tokyo), Shen Xi-yue (Shanghai)

×
Search :
#Presenter1st AuthorAbs codeTitle
1Quincy Mae CenizaQuincy Mae Ceniza01.1Pleural Mycobacterium abscessus Diagnosed by PCR Despite Negative Cultures in a Patient with Treated Tuberculosis and Metastatic Lung Adenocarcinoma
2Isano HaseIsano Hase01.2Atypical Chest Computed Tomography Findings in Disseminated Nontuberculous Mycobacterial Infection Associated with Adult-Onset Immunodeficiency
3Yuri HiramatsuYuri Hiramatsu01.3Association Between Lobar Distribution of Bronchiectasis and Sputum Pathogen Detection
4Hamza MdHamza Md01.4Molecular Detection and Clinical Correlates of Non-Tuberculous Mycobacteria among Presumptive Tuberculosis Patients at a Tertiary Care Hospital: A Cross-Sectional Study
5Atsuhiro NaganoAtsuhiro Nagano01.5Bronchoscopy for the Diagnosis of Pulmonary Nontuberculous Mycobacterial Disease: A Retrospective Study
6Temma NakagawaTemma Nakagawa01.6Leveraging Machine Learning to Identify Minimal Gene Panels for High-Accuracy Subspecies-Level Typing of Nontuberculous Mycobacteria
7Disha PhadtareDisha Phadtare01.7BEYOND TB, NTM IN A DOCTOR – UNEXPECTED DIAGNOSIS IN AN IMMUNOCOMPETANT ADULT

 

Poster Session 2 – Management

Chairs: Stefano Aliberti (Milano), Lucy Morgan (Sydney)

Search :

#Presenter1st AuthorAbs codeTitle
1Azza OmarTasnim Abdul Aziz02.1Living Well with Bruton Disease: Long-Term Stability of Bronchiectasis Through Comprehensive Management
2Chih-Jung ChangChih-Jung Chang02.2Clinical Impact of Cavitation on Treatment Outcomes in Mycobacterium kansasii Lung Disease
3Chloe CheongChloe Cheong02.3Evaluating and Predicting Disease Progression of Non-Tuberculous Mycobacterial Lung Disease Using Cases from the Royal Melbourne Hospital
4Bumhee YangMinyoung Kim02.4Sputum Myeloperoxidase Concentration and Future Risk of Exacerbations in Bronchiectasis
5Shital Vishnu PatilShital Vishnu Patil02.5Effect of Erdosteine, Azithromycin, and Combination Therapy on Clinical and Immunological Outcomes in Patients with Bronchiectasis: A multicentre Comparative efficacy 52 weeks Study
6Nana KozukiNana Kozuki02.6Efficacy of Amikacin Liposome Inhalation Suspension in refractory Mycobacterium avium complex pulmonary disease and patient-reported outcomes

 

Poster Session 3 – Co-infections

Chairs: Hua Zhou (Zhejiang), Naoki Iwanaga (Nagasaki)

Search :

#Presenter1st AuthorAbs codeTitle
1Ying-Chun ChienYing-Chun Chien03.2Respiratory Microbial Co-isolation, Aspergillus Antigen Positivity, and Survival in Critically Ill Patients With NTM Lung Disease or Tuberculosis
2Jabeen KauserAhmed Imran03.3Concomitant isolation of non-tuberculous mycobacteria and Aspergillus species in patients with bronchiectasis: a laboratory-based data
3Worarat ImsanguanWorarat Imsanguan03.4When One Pathogen Paves The Way: Chronic pulmonary aspergillosis arising from Refractory Mycobacterium masiliense pulmonary disease
4Katy LaiKaty Lai03.5Mycobacterium tuberculosis and Mycobacterium abscessus Pulmonary Coinfection in a Patient with Bronchiectasis: A Diagnostic and Therapeutic Challenge
5Muhammad SarwarMuhammad Sarwar03.6Post-Tuberculosis versus Non-Post-Tuberculosis Bronchiectasis: Clinical, Microbiological and Radiological Characteristics of a Real-World Pakistani Cohort
6Simran SharmaSimran Sharma03.7Post-tuberculosis cavitary bronchiectasis with respiratory failure in an older adult: the importance of distinguishing structural lung disease from active infection

 

Poster Session 4 – Refractory NTM

Chairs: Kozo Morimoto (Tokyo), Tone Kazuya (Chiba)

Search :

#Presenter1st AuthorAbs codeTitle
1Snehal KawadeSnehal Kawade04.1Refractory Mycobacterium fortuitum Pulmonary Disease Masquerading as Tuberculosis in a Patient with Occupational Silicosis and COPD
2Yin Ling LeeYin Ling Lee04.2Disseminated Mycobacterium abscessus Infection with Anti-Interferon-Gamma Autoantibody Immunodeficiency – A Case Report
3Kirby Patterson-FahyKirby Patterson-Fahy04.3Mycobacterium abscessus clinical isolates are susceptible to epetraborole in vitro
4Yuya TanakaYuya Tanaka04.4Fatal Acute Respiratory Deterioration Following Amikacin Liposome Inhalation Suspension in a Patient with Idiopathic Pulmonary Fibrosis
5Matthew TwiningMatthew Twining04.5Combination beta-lactam antibiotic salvage therapy for refractory Mycobacterium avium complex pulmonary disease (MAC-PD).
6Wen Jun Lawrence WongWen Jun Lawrence Wong04.6A culture of uncertainty: A review of microbiological reassessment and treatment decisions across repeated treatment courses of Mycobacterium abscessus pulmonary disease – a retrospective case series

 

Poster Session 5 – Pathophysiology

Chairs: Chiao-Feng Cheng (Taipei), Keisuke Kamada (Hokkaido)

Search :

#Presenter1st AuthorAbs codeTitle
1Thi Ngoc Huyen DaoThi Ngoc Huyen Dao05.1ASSESSING AIRWAY INFLAMMATION VIA NEUTROPHIL ELASTASE ACTIVITY IN BRONCHIECTASIS PATIENTS: BRONCHOSCOPY-TARGETED SAMPLING VERSUS SPUTUM
2ARJUN KHANNAARJUN KHANNA05.2INFLAMMATORY MARKERS IN BIOMASS FUEL ASSOCIATED COPD-BRONCHIECTASIS – IS TH2 INFLAMMATION THE MISSING LINK?
3Shital Vishnu PatilShital Vishnu Patil05.3COPD–Bronchiectasis Overlap Syndrome: A Heterogeneous Chronic Airway Disease with Diverse Clinical Presentations
4Chie WatanabeChie Watanabe05.4Integrated Tissue-to-Cell Profiling Reveals Disease-Linked Neutrophil States and Neutrophil Extracellular Trap Formation in Nontuberculous Mycobacterial Pulmonary Disease
5Yimin ZhuYimin Zhu05.5Proteomic profiling of Dipeptidyl Peptidase-1 inhibition reveals proteolytic remodelling in murine lung inflammation

 

Poster Session 6 – Aetiology

Chairs: Kei Nakashima (Chiba), Yue Su (Shanghai)

Search :

#Presenter1st AuthorAbs codeTitle
1N L A DissanayakeN L A Dissanayake06.1Comorbidities in Patients with Bronchiectasis Admitted to a Tertiary Care Respiratory Unit in Sri Lanka: Descriptive Cross-Sectional Study with Retrospective Data Extraction
2Sheikh Nazmul IslamSheikh Nazmul Islam06.2Investigating Bronchiectasis: One Key – Opening Many Locks
3Snehal KawadeSnehal Kawade06.3Beyond the Airways: Bronchiectasis as the Presenting Face of Young Syndrome and Kartagener Syndrome — A Case Series
4Toshifumi ShibataToshifumi Shibata06.4Distribution Patterns of Bronchial Dilatation According to Etiology
5DR DIVYA WANKHEDEDR DIVYA WANKHEDE06.5From Diagnosis to Severity: Serum Total IgE mirrors lung function in ABPA associated Bronchiectasis
6Bumhee YangBumhee Yang06.6Unveiling of Tuberculosis-Bronchiectasis using Single-cell PBMC Immune Profiling

 

Poster Session 7 – Epidemiology

Chairs: Yeon-Mok Oh (Seoul), Kevin Winthrop (Portland)

Search :

#Presenter1st AuthorAbs codeTitle
1Rachel M. ThomsonMelinda Ashcroft07.1Temporal trends and spatial variation in nontuberculous mycobacterial incidence among First Nations people in Queensland, Australia
2Ivy CastroIvy Castro07.2CLINICODEMOGRAPHIC PROFILE AND IN-HOSPITAL OUTCOMES OF PATIENTS WITH BRONCHIECTASIS ADMITTED IN A TERTIARY HOSPITAL IN CEBU CITY
3Hasan JamilHasan Jamil07.3Satellite-measured environmental conditions and reported nontuberculous mycobacterial disease across Japan's 47 prefectures, an ecological study
4Linda KunzLinda Kunz07.4Gender differences in bronchiectasis – filling the gender data gap
5Chia-Jung LiuChia-Jung Liu07.5Refining mortality risk prediction in nontuberculous mycobacterial lung disease: The BACS-C Score
6Atha Rifqia PradanaAtha Rifqia Pradana07.6Pulmonary nontuberculous mycobacterial incidence across Australia, Cambodia, Japan, Thailand, and the United States: a multi-country epidemiologic comparison.
7Pichanee WatthanasiriPichanee Watthanasiri07.7Spatiotemporal Patterns of Nontuberculous Mycobacterial Pulmonary Disease in Thailand, 2015–2024

 

 

Poster Session 8 – Airway Clearance, Treatments

Chairs: Ryo Kozu (Nagazaki), Annemarie Lee (Melbourne)

Search :

#Presenter1st AuthorAbs codeTitle
1Yea Rin ChoYea Rin Cho08.1Microbiological Impact of Airway Clearance Technique and Pulmonary Rehabilitation in NTM-PD: A preliminary IPTW-adjusted landmark analysis
2Isaac CohenIsaac Cohen08.2MCCSA2 a Combination of the b- agonist Formoterol and the Cholinergic Agonist Methacholine Induce Synergistic Activation of Mucociliary Clearance in a CFTR Independent Manner
3Koki FukushimaKoki Fukushima08.3Prevotella intermedia culture supernatant induced secondary ciliary dyskinesia in mouse airways and in human airway epithelial cells.
4Ern-Wei PeckErn-Wei Peck08.4Biologic therapy in Type 2 Asthma–Bronchiectasis overlap: a case series
5Sivagurunathan SutharsanSivagurunathan Sutharsan08.5Airway Clearance in Bronchiectasis and NTM: Hospital and Home-Based vane-generated OPEP Use — Experience of a Reference Center in Germany
6Bryan TinBryan Tin08.6Adherence to Airway Clearance Techniques (ACT) in Primary Ciliary Dyskinesia (PCD): The Role of Diagnostic Age and Disease Duration

 

 

Poster Session 9 – Diagnosis

Chairs: Timothy Aksamit (Rochester), Worarat Imsanguan (Chang Rai)

Search :

#Presenter1st AuthorAbs codeTitle
1Shin IizukaShin Iizuka09.1Portable tidal-breathing nasal nitric oxide in the multimodal assessment of suspected primary ciliary dyskinesia among Japanese patients with bronchiectasis
2Jee Youn OhJee Youn Oh09.2A simple clinical score to distinguish nontuberculous mycobacterial pulmonary disease from pulmonary tuberculosis at first evaluation
3Kirby Patterson-FahyKirby Patterson-Fahy09.3Does lidocaine affect nontuberculous mycobacteria yield from bronchoalveolar lavage?
4Inthira SimapichetInthira Simapichet09.4High Risk, High Recurrence: Recurrent Mycobacterium infection in a patient with polysubstance use.
5DR DIVYA WANKHEDEDR DIVYA WANKHEDE09.5Beyond Obstruction: The Spirometric Spectrum in a 300-Patient Post-Tuberculosis Bronchiectasis Cohort

 

 

Poster Session 10 – Management

Chairs: Raja Dhar (Kolkata), Thu Phuong Phan (Hanoi)

Search :

#Presenter1st AuthorAbs codeTitle
1Ernest PohAnmol Kaur10.1Beyond Airway Clearance: Referral Trends and Functional Exercise Outcomes in Bronchiectasis at a Tertiary Outpatient Physiotherapy Service
2Quincy Mae CenizaQuincy Mae Ceniza10.2Asymmetric High-Flow Nasal Cannula as an Alternative to Non-Invasive Ventilation in Type II Respiratory Failure in a Patient with Post-Tuberculosis Bronchiectasis
3Ye Jin LeeYea Rin Cho10.3Association Between Regular Inhaled Corticosteroid Use and 2-Year Radiographic Progression of NTM Pulmonary Disease in Patients With Bronchiectasis
4Jacob ChristensenJacob Christensen10.4Real-world Effectiveness, Tolerability and Safety Monitoring of Long-term Azithromycin Therapy for Adults with Non-Cystic Fibrosis Bronchiectasis: A Retrospective Cohort Study
5Yuka MiyoshiYuka Miyoshi10.5Clinical Utility of Bronchoscopy Before Treatment Completion in Nontuberculous Mycobacterial Pulmonary Disease
6Youngmok ParkYoungmok Park10.6Neutrophil-to-lymphocyte ratio is independently associated with disease burden in Nontuberculous Mycobacterial Pulmonary Disease

 

 

Poster Session 11 – Aetiology, Comorbidities

Chairs: Anne Chang (Brisbane), Ho Namkoong (Tokyo)

Search :

#Presenter1st AuthorAbs codeTitle
1Heidelyn AguilarHeidelyn Aguilar11.1Post-Tuberculosis Bronchiectasis With Suspected Pulmonary Hypertension and Right Heart Failure in a Young Woman
2Thi Ngoc Huyen DaoThi Ngoc Huyen Dao11.2CLINICAL CHARACTERISTICS AND BACTERIOLOGY IN EXACERBATION OF BRONCHIECTASIS PATIENTS AT THE PULMONOLOGY DEPARTMENT IN UNIVERSITY MEDICAL CENTER, HO CHI MINH CITY
3Muhammad IrfanNousheen Iqbal11.3Nontuberculous mycobacteria (NTM) pulmonary infection: A single centre study, an experience from a TB endemic developing country
4Ernest PohMANN WEI LIM11.4Clinical Characteristics and Outcomes of Malaysian Adults with Bronchiectasis: A Real-World Cohort
5Disha PhadtareDisha Phadtare11.5WHEN POST-TB BRONCHIECTASIS WASN’T THE WHOLE STORY: ABPA WITH CENTRAL BRONCHIECTASIS IN POST TB SEQUELAE
6Jessica Quah LishanJessica Quah Lishan11.6From Reflux to Bronchiectasis: Progressive Non-Cystic Fibrosis Bronchiectasis Secondary to Hiatal Hernia-Associated Gastroesophageal Reflux Disease
7Charlotte SieberCharlotte Sieber11.7Sleep-related breathing disorders in patients with non-cystic fibrosis bronchiectasis: a prospective single-centre study
8Merlyn VadakkanMerlyn Vadakkan11.8A rare case of Kartegener's Syndrome

 

 

Poster Session 12 – Environmental conditions, Microbiome

Chairs: Sanjay H. Chotirmall (Singapore), Scott Bell (Brisbane)

Search :

#Presenter1st AuthorAbs codeTitle
1Tim BairdTim Baird12.1Using Metagenomics to Advance Precision-Based Bronchiectasis Management
2N L A DissanayakeN L A Dissanayake12.2Bacteriological and Radiological Profiles of Bronchiectasis Patients in a Tertiary Care Hospital, Sri Lanka: A Descriptive Cross-Sectional Study
3Masashi ItoMasashi Ito12.3Detection of Mycobacterium avium in Bathtub Water Is Associated with Recurrence
4Lisa KawatsuKozo Morimoto12.4Geographic and Seasonal Distribution of Nontuberculous Mycobacterial Disease in Japan: A Nationwide Climate-Zone-Based Analysis using laboratory-based data
5Atha Rifqia PradanaAtha Rifqia Pradana12.5Climatic drivers of NTM pulmonary infection vary across Queensland, Australia: Evidence from Köppen climate zones.
6Ming Ren TohMing Ren Toh12.6Respiratory microbiology in Asthma-Bronchiectasis Overlap: findings from a longitudinal real-world study

 

Poster Session 13 – Bacteriophage therapy, Clinical Trial, Comorbidities, Epidemiology, Surgical Treatments

Chairs: Doreen Addrizzo-Harris (New York), Chin-Chung Shu (Taipei)

Search :

#Presenter1st AuthorAbs codeTitle
1Akinari AtsumiAkinari Atsumi13.1Outcomes of One-Stage Bilateral Pulmonary Resection via Median Sternotomy for Nontuberculous Mycobacterial Pulmonary Disease
2Jun AtsumiJun Atsumi13.2Single-stage right upper and lower lobectomy with middle-lobe preservation for localized Mycobacterium abscessus subsp. abscessus pulmonary disease and bronchiectasis
3koya Itokoya Ito13.3Bronchoscopic Microbiological Findings and Bronchoalveolar Cellular and T-Cell Profiles in Bronchiectasis and Bronchiolitis
4Ayanna Denise LariosaAyanna Denise Lariosa13.4Post Tuberculosis Bronchiectasis with Suspected Pulmonary Hypertension and Constrictive Pericarditis in a Young Filipino Man
5James D. ChalmersMichal Shteinberg13.5Final overall pooled data, including severe pulmonary exacerbations, from Phase II studies (AIRLEAF®, CLAIRLEAF®) of the dipeptidyl peptidase 1 (or cathepsin C) inhibitor verducatib in bronchiectasis
6Kevin L. WinthropKevin L. Winthrop13.6Brensocatib in patients with non-cystic fibrosis bronchiectasis and history of nontuberculous mycobacteria infection: A post-hoc analysis of the ASPEN trial
7Dillon Guo Dong YeoDillon Guo Dong Yeo13.7Are we on the same phage? Bacteriophage therapy for non-tuberculous mycobacterial pulmonary disease – a scoping review

 

APBC2026 IS JUST AROUND THE CORNER!

 
The conference is fast approaching! Register now to secure your place at the 1st Asia-Pacific Bronchiectasis & NTM Conference 2026.
 
Join leading experts to share knowledge, explore the latest advances, and connect with colleagues from across the globe.

ABSTRACT SUBMISSION IS NOW CLOSED

  • Late-Breaking Abstract Submission
  • The Late-Breaking Abstract submission window will open from 5–15 October 2026.
  • Early Registration Fee Deadline: 30 September 2026
Don’t miss the opportunity to join leading bronchiectasis and NTM experts in Tokyo, 13–15 November 2026. Register by 30 September 2026 to take advantage of the Early Registration Fee.